Clinical Trial Update: Phase II Study of Forodesine in Subjects With Chronic Lymphocytic Leukemia (CLL) [Phase 2]

View source ↗

Summary

Phase II clinical trial of forodesine in chronic lymphocytic leukemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• Forodesine (forodesine)

Snippet

Sponsor: BioCryst Pharmaceuticals | Conditions: Chronic Lymphocytic Leukemia (CLL) | Phase 2 | Status: COMPLETED